NCT05156333 is a NA clinical trial of Respecta in GBS Rectovaginal Colonization, sponsored by University of Modena and Reggio Emilia.

Who is sponsoring NCT05156333?

NCT05156333 is sponsored by University of Modena and Reggio Emilia.

What drugs are being tested in NCT05156333?

Interventions in NCT05156333: Respecta.

What condition does NCT05156333 study?

NCT05156333 studies GBS Rectovaginal Colonization, Neonatal Sepsis.

Is NCT05156333 still recruiting?

NCT05156333 is currently suspended. Last updated 7 November 2022.

Last reviewed 2022-11-07 · How we verify

NCT05156333

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotics and GBS Colonization in Pregnancy

Suspended NA Last updated 7 November 2022

What this trial tests

NA trial testing Respecta in GBS Rectovaginal Colonization in 402 participants. Suspended.

Timeline

15 October 2020

Primary endpoint
30 September 2022

31 December 2022

Quick facts

Lead sponsor	University of Modena and Reggio Emilia
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	402
Start date	15 October 2020
Primary completion	30 September 2022
Estimated completion	31 December 2022
Sites	3 locations across Italy

Drugs / interventions tested

Respecta

Conditions studied

GBS Rectovaginal Colonization — all drugs for GBS Rectovaginal Colonization →
Neonatal Sepsis — all drugs for Neonatal Sepsis →

Sponsor

University of Modena and Reggio Emilia

Who can join

Adults 18 to 45, female only, with GBS Rectovaginal Colonization or Neonatal Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicentric, randomized, placebo-controlled, double-blind, parallel group study aimed at evaluating the feasibility and effect of the use of probiotic starting from the 30th week, on vaginal / rectal colonization of GBS in women at low obstetric risk.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Modena and Reggio Emilia trials

Trials by the same sponsor.

NCT05282238 — Quantification of Inspiratory Effort Through Nasal Pressure in Patients Undergoing Weaning From Invasive Mechanical Vent · not yet recruiting
NCT07404423 — OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis · not yet recruiting
NCT06989385 — CORALINE - Correlation Between Physiological and Clinical Variables and Failure of Non-Invasive Respiratory Support in P · recruiting
NCT06734949 — CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD · enrolling by invitation
NCT05043753 — "Fetal gRowth AbnorMality dEtection Trial" · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05156333 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Modena and Reggio Emilia
Last refreshed: 7 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing